Join Zoom Meeting
https://mc-meet.zoom.us/j/95861380114?pwd=WThqQ2ZxM1l5SlVVV1lWNUN4WTl0UT09

Meeting ID: 958 6138 0114
Passcode: 188969

Visiting Physician
Prof John Hardy
"Genetic findings converge on discrete pathways in neurodegenerative disease"

Learning objectives: 
Upon conclusion of this activity, participants will be able to:

• Summarize the likely role of microglia in Alzheimer’s pathogenesis
• Assess the potential roles of lysosomal insufficiency in Lewy body disorders and the ubiquitin proteasome in tangle diseases
• Describe why many elderly have multiple pathologies

Prof Hardy does have relevant financial relationships to disclose: Consulting – Eli Lilly, Eisai, Roche; Stock, stock options Ceracuity (Biotec start up) and does intend to discuss off-label/investigative use of Pharmaceuticals or Instruments: Expected to be asked about aducanemab and lecanemab the treatment of Alzhelmers disease.  These are Eisai drugs from whom he has consulted.  He has not been involved in these programmes. 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.